Specialty code 183500000X · South San Francisco, CA
NPI
1831275122
Since 2006
Specialty
Specialty code 183500000X
Code 183500000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1200 El Camino Real
South San Francisco, CA, 94080
Phone (415) 203-4714
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$181K
1,196 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Sarah S Louie prescribed most often to Medicare patients was Metformin Hcl, with 178 prescriptions and refills. In total Sarah S Louie wrote 1,196 Medicare prescriptions that cost $181K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-10.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Metformin Hcl Generic | 178 | 588 | 69 | $2,402 |
| Atorvastatin Calcium Generic | 132 | 439 | 44 | $1,642 |
| Glipizide Generic | 124 | 413 | 47 | $1,800 |
| Metformin Hcl Er Metformin Hcl | 109 | 363 | 37 | $1,093 |
| Humulin N Insulin Nph Human Isophane | 98 | 310 | 36 | $29K |
| Ozempic Semaglutide | 61 | 61 | 11 | $45K |
| Glipizide Er Glipizide | 59 | 187 | 21 | $1,663 |
| Veo Insulin Syringe Syringe-Needle,insulin,0.5 Ml | 55 | 178 | 19 | $1,372 |
| Simvastatin Generic | 51 | 170 | 16 | $602 |
| Jardiance Empagliflozin | 42 | 140 | 14 | $23K |
| Humulin N Kwikpen Insulin Nph Human Isophane | 41 | 112 | 15 | $9,279 |
| Pioglitazone Hcl Generic | 40 | 133 | 15 | $486 |
| Ultra-Fine Nano Pen Needle Pen Needle, Diabetic | 39 | 125 | 15 | $902 |
| Insulin Glargine-Yfgn Generic | 34 | 105 | 18 | $5,425 |
| Veo Insulin Syringe Syringe And Needle,insulin,1ml | 31 | 93 | 13 | $843 |
Brand drugs: 348 claims; generic drugs: 708 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Sarah S Louie were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.